HK
SCR

Horizon Kinetics’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Horizon Kinetics’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-48,000
Closed -$454K – 559
2013
Q3 		$454K Hold
48,000
– – 0.01% 318
2013
Q2 		$455K Buy
+48,000
New +$444K 0.01% 331

Other funds holding SCR

SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
LOM
Loeb Offshore Management New York $547M AUM 50.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Horizon Kinetics's SCR Position: Q4 2013 in Review

Horizon Kinetics sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q4 2013, closing a stake of 48,000 shares — an estimated $454K sold.

Horizon Kinetics first reported a position in SCR in Q2 2013 and held it in 2 quarters. The position peaked at $455K in Q2 2013. 12 funds tracked by Wall St. Rank hold SCR as of Q4 2013.

  • Horizon Kinetics reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q4 2013 after selling out during the quarter.
  • Horizon Kinetics sold 48,000 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q4 2013, an estimated $454K.
  • Horizon Kinetics first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q2 2013 and held it in 2 quarters.
  • Horizon Kinetics's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $455K in Q2 2013.
  • 12 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q4 2013.

Based on Horizon Kinetics's 13F filing for Q4 2013, filed 13 Feb 2014.